FDA Inspection
OU HealthOU Health – FDA Inspection, Oct 28, 2024
Record Details
This FDA Inspection record concerns OU Health, with an inspection on October 28, 2024, issued by the Dallas District Office, covering biologics.
View Company Profile
ID · c53d8da6-7234-40c1-972b-bbf48c478bc2
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1252564
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 1271.55(a)(2)Eligibility statement--basis of determination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of OU Health
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 29, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 21, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 15, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 5, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 3, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for OU Health
- FDA Inspection 1091552 - 2019-04-29
- FDA Inspection 1021584 - 2017-06-21
- FDA Inspection 909982 - 2014-12-15
- FDA Inspection 808849 - 2012-10-05
- FDA Inspection 725767 - 2011-05-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.